Results 91 to 100 of about 5,165 (174)

Active Site Mutations of Pseudomonas aeruginosa Exotoxin A [PDF]

Journal of Biological Chemistry, 1995
Xiang Y. Han, Darrell R. Galloway
openaire   +1 more source

<i>Pseudomonas aeruginosa</i> Pathogenicity and Its Interaction with Other Microorganisms During the Skin Wound Healing Process. [PDF]

Int J Mol Sci
Yamberla I, Pupiales C, Chiliquinga AJ, Sulca-Villamarín T, Plasencia A, Cabrera Aulestia F, Díaz RF, Caicedo A, Barba PM.   +8 more
europepmc   +1 more source

Insight into the Catalytic Mechanism of Pseudomonas aeruginosa Exotoxin A [PDF]

Journal of Biological Chemistry, 2002
Souzan Armstrong, Susan P. Yates, A. Rod Merrill   +2 more
openaire   +1 more source

Genetic mutations enhance the production of Exotoxin A by <i>Pseudomonas aeruginosa</i> for use as a potential anticancer therapeutic agent. [PDF]

Exp Ther Med
Almami IS.
europepmc   +1 more source

The Brief Case: Pneumonia in a <i>Boa constrictor occidentalis</i> with inclusion body disease caused by multidrug-resistant VIM-type metallo-β-lactamase producing <i>Pseudomonas aeruginosa</i>. [PDF]

J Clin Microbiol
Broering Ferreira A, Pilegi Sfaciotte RA, Fagundes LDEM, Peterle H, Veiga RF, Vieira S, Carneiro RK, Costa UMd, Ferraz SM.   +8 more
europepmc   +1 more source

Developing a Pseudomonas aeruginosa keratitis model in Swiss albino mice for clinical assessment. [PDF]

Indian J Med Res
Arya LK, Kumari A, Kusumesh R, Kumar P, Sinha BP, Kumar M, Kumari N.   +6 more
europepmc   +1 more source

Landscape of resistance to ceftolozane/tazobactam and ceftazidime/avibactam in strains of Pseudomonas aeruginosa: a genomic approach in strains without selection pressure in a tertiary-care paediatric hospital in Mexico. [PDF]

BMC Infect Dis
A Méndez HE, Merida-Vieyra J, Aparicio-Ozores G, Hernández-Durán M, Méndez-Tenorio A, Tapia-Reyes A, Bautista-Hernandez R, Juárez-Hinojos D, Aquino-Andrade A.   +8 more
europepmc   +1 more source

Clearance of hypermutator XDR <i>Pseudomonas</i> osteomyelitis and hardware infection with adjunctive bacteriophage therapy. [PDF]

ASM Case Rep
Ngauy V, Bevans S, Kido D, Ibrahimovic R, Kamau E, Caldwell A, Pangilinan R, Levit R, Lebreton F, Filippov AA, Luo TL, Ellison DW, Nikolich MP, McGann P.   +13 more
europepmc   +1 more source

The presence of exotoxin genes and biofilm production in carbapenem-resistant <i>Pseudomonas aeruginosa</i> clinical isolates. [PDF]

Germs
Thabit AG, Sediek MN, Mohamed MSE.
europepmc   +1 more source

A decade of insight into ExlA toxin research and the biotechnological potential of non-virulent <i>Pseudomonas aeruginosa</i> strains. [PDF]

J Bacteriol
García-Reyes S.
europepmc   +1 more source